AKT1 and systemic lupus erythematosus: To elucidate the alterations in glucose metabolism and HSP90AA1/PI3K/AKT signaling pathway activity in lupus prone mice with hUC‐MSCs treatment, we analyzed the levels of glucose metabolites and relevant signaling components.